RecruitingNot ApplicableNCT06271941

Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

892 participants

Start Date

Jul 19, 2024

Study Type

INTERVENTIONAL

Conditions

Colorectal, Cancer Polyp of Colon

Summary

Large (≥20mm) colorectal polyps often harbor areas of advanced neoplasia, making them immediate colorectal cancer (CRC) precursors. Such polyps have to be completely removed to prevent CRC and to avoid surgery and/or adjuvant therapy. The laterally spreading lesions (LSLs) are removed via endoscopic mucosal resection (EMR). However, recurrence is common. New techniques for LSL resection (hybrid argon plasma coagulation (h-APC) margin and base ablation) have shown a reduction in recurrence following the interventions. We hypothesize that performing hybrid argon plasma coagulation (h-APC) margin and base ablation during EMR of large (≥20mm) colorectal LSLs will lead to lower rates of lesion recurrence compared to Snare tip soft coagulation (STSC) margin ablation.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing approaches to reduce the recurrence of large colorectal polyps (20mm or bigger) after they are removed during a colonoscopy using a procedure called endoscopic mucosal resection (EMR). Polyps that are not fully removed can grow back and become cancerous. **You may be eligible if...** - You are 18 or older - You are having a colonoscopy to remove a large colorectal polyp (20mm or larger) - You are willing to give informed consent **You may NOT be eligible if...** - You have inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) - Your polyp shows signs of invasive cancer - You have blood clotting problems - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHybrid Argon Plasma Coagulation (h-APC)

The hybrid argon plasma coagulation (h-APC) combines an ablation technique (APC) with the option for submucosal saline injection using a high-pressure water jet. The technique allows for the lifting of dysplastic epithelium, creating a cushion under the mucosa to facilitate the ablation of larger areas more thoroughly and with higher energy settings, while posing a low risk for side effects or complications.

PROCEDURESnare tip soft coagulation (STSC)

The Snare tip soft coagulation (STSC) involves using a snare to remove polyps, while simultaneously applying soft coagulation to the surrounding tissue using a specialized tip on the snare.